“2030: annual revenue between approximately €44 billion and €60 billion with a gross margin between approximately 56% and 60%.”
Target confirmed again at ASML's 2024 Investor Day; 2026 guidance of €43–45 billion puts the low end of the 2030 range within reach four years early.